Standardized botanical active evaluation, pharmacological assay systems, and end-to-end contract development services.
The Traditional Chinese Medicine (TCM) manufacturing sector in China has evolved from empirical herbal craftsmanship into an advanced, data-driven biopharmaceutical domain. As international regulatory bodies such as the US FDA, European EMA, and WHO tighten botanical safety metrics, qualified Chinese manufacturers stand at the pivotal nexus of chemistry, manufacturing, and controls (CMC).
Moving beyond ambiguous extract labeling, modern Chinese factories deploy high-performance thin-layer chromatography (HPTLC), HPLC-MS, and GC-FID fingerprinting to confirm chemical consistency, eliminating batch variation in natural harvests.
In traditional terminology known as 'Dao-Di' (geo-authentic origin), modern suppliers establish Good Agricultural and Collection Practices (GACP) directly in native ecosystems to preserve targeted secondary metabolite profiles.
Strict quantification of pesticide residues, heavy metals (Pb, Cd, As, Hg), mycotoxins, and solvent residues according to European Pharmacopoeia (EP) and United States Pharmacopeia (USP) monographs.
Navigating global botanical procurement requires balancing technical compliance with commercial viability. Partnering directly with tier-one Chinese TCM manufacturers offers unparalleled advantages across the procurement life-cycle.
Direct oversight spanning seed provenance, botanical cultivation bases, primary drying, standardized fluid extraction, continuous crystallization, to clean-room packaging.
Massive automated continuous countercurrent extraction lines process thousands of metric tons annually, drastically lowering operational costs compared to Western contract extractors.
Access to decades of deep chromatographic baseline references, reference standards, and proprietary separation protocols developed across nearly 400 single-herb monographs.
Effortless scale-up pathways connecting laboratory micro-extractions, 50-liter pilot test reactors, and full-scale 10,000-liter GMP commercial fermentation and extraction tanks.
Quantifiable scientific authority built through long-term research programs with China's top medical academies and multinational pharmaceutical brands.
Overseas procurement teams face rigorous scrutiny from border control, food and drug administrations, and third-party testing labs. We turn localized compliance into a decisive competitive advantage for our partners.
We author full Drug Master Files (DMF), Certificates of Analysis (CoA), technical data sheets (TDS), and stability profiles (accelerated and long-term storage under ICH Q1A guidelines).
Proprietary super-critical fluid extraction (SFE-CO2) and macroporous resin chromatography remove polycyclic aromatic hydrocarbons (PAHs), ethylene oxide (EtO), and over 500 pesticide screens.
Fully documented batch records allow instant forward and backward traceability to specific agronomic plots, harvest dates, solvent recovery batches, and qualified transportation routes.
The integration of artificial intelligence in phytochemistry, microencapsulation technology, and metabolic targeting is opening transformative commercial opportunities for plant-derived formulations worldwide.
Water-soluble botanical extracts and high-absorption granulations for dietary supplements targeting adaptogenic stress response, metabolic health, cognitive vitality, and immune support.
Standardized multi-component botanical drug candidates passing clinical phase gate reviews, backed by comprehensive preclinical safety packages, LD50 profiles, and pharmacokinetics (PK).
Clinically proven natural anti-inflammatory, antioxidant, and anti-aging phyto-actives providing organic alternatives to synthetic active ingredients for international skincare brands.
Every study phase delivers clear, audit-ready data milestones ensuring project timeline transparency, risk containment, and milestone-governed financial commitments.
Identify superior plant taxa, optimal seasonal harvest windows, and high-density active anatomical structures to maximize yield efficiency.
Formulate robust HPTLC, HPLC, and GC chromatographic fingerprinting methods to assure definitive batch-to-batch chemical identity.
Refine solid-liquid pretreatment, continuous countercurrent extraction, drying parameters, and solvent recycling for commercial feasibility.
Execute GLP-compliant in vitro cell screening, in vivo animal models, LD50 acute assays, and genotoxicity panels.
Design and supervise targeted human efficacy trials for dietary claims or complete multi-phase clinical investigations for NDA dossiers.
Full-scale commercial packaging in certified finished dosage formats: oral liquids, softgels, capsules, effervescent granules, and bulk pastes.
Longstanding co-development, standard-setting, and bulk CDMO partnerships with premier health institutions.
Strategic, regulatory, and operational considerations when selecting a Traditional Chinese Medicine CRO/CDMO partner.
Select from our validated active ingredient libraries or contract tailored pharmaceutical analytical development.
Accelerate your botanical product development timeline with China's premier Traditional Chinese Medicine CRO/CDMO partner. Receive tailored study protocols, chromatographic assay designs, and commercial batch supply forecasts.